Massachusetts Lawmakers Prioritize Health Policy
Katherine O'Malley
August 12, 2026
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
6 Things That Happened in Health Policy This Week is produced by a mix of research assistants from the Healthcare Quality & Outcomes (HQO) Initiative
Every time health care reform comes up for debate, I see people arguing about whether a publicly or privately funded system would be better. The
So far, in discussing the financial incentives that the Orphan Drug Act creates for drug manufacturers, I’ve focused exclusively on the seven-year exclusivity period. But
In my last post, I canvassed two common ways that manufacturers game the Orphan Drug Act. Today I’ll cover the third—“salami slicing.” Many common diseases
Medicare Beneficiaries Face Growing Out-Of-Pocket Burden For Specialty Drugs While In Catastrophic Coverage Phase, Health Affairs Part D Generic Drug Prices Declined Overall, but Some Had Extraordinary Price Increases,
Even if the Orphan Drug Act were working properly, its enormous costs might outweigh its exiguous benefits. But it’s not working properly. Drug manufacturers are
The following originally appeared on The Upshot (copyright 2016, The New York Times Company). Hospitals and many insurance carriers care about patient satisfaction. It especially matters to
When my wife’s water broke, minutes after I went to bed back in January of 2002, I remember driving her to the hospital and anguishing
In a January memo to Senator Rubio, the Congressional Research Service laid out an argument for why the Obama administration can’t use the Judgment Fund
The Obama administration made news on Friday afternoon when it announced that it was open to discussing settlements with health plans that have sued the
As of this summer, I’m serving as an associate editor for the Journal of Health Politics, Policy, and Law. If you’re a health-policy junkie, you